These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Discovery of potent inhibitors of the lysophospholipase autotaxin. Shah P; Cheasty A; Foxton C; Raynham T; Farooq M; Gutierrez IF; Lejeune A; Pritchard M; Turnbull A; Pang L; Owen P; Boyd S; Stowell A; Jordan A; Hamilton NM; Hitchin JR; Stockley M; MacDonald E; Quesada MJ; Trivier E; Skeete J; Ovaa H; Moolenaar WH; Ryder H Bioorg Med Chem Lett; 2016 Nov; 26(22):5403-5410. PubMed ID: 27780639 [TBL] [Abstract][Full Text] [Related]
5. Discovery of small-molecule enzyme activators by activity-based protein profiling. Kok BP; Ghimire S; Kim W; Chatterjee S; Johns T; Kitamura S; Eberhardt J; Ogasawara D; Xu J; Sukiasyan A; Kim SM; Godio C; Bittencourt JM; Cameron M; Galmozzi A; Forli S; Wolan DW; Cravatt BF; Boger DL; Saez E Nat Chem Biol; 2020 Sep; 16(9):997-1005. PubMed ID: 32514184 [TBL] [Abstract][Full Text] [Related]
6. Fluorescence probe for lysophospholipase C/NPP6 activity and a potent NPP6 inhibitor. Kawaguchi M; Okabe T; Okudaira S; Hanaoka K; Fujikawa Y; Terai T; Komatsu T; Kojima H; Aoki J; Nagano T J Am Chem Soc; 2011 Aug; 133(31):12021-30. PubMed ID: 21721554 [TBL] [Abstract][Full Text] [Related]
7. Lysophospholipase from the human blood fluke, Schistosoma japonicum. Fan J; Yang W; Brindley PJ Int J Infect Dis; 2008 Mar; 12(2):143-51. PubMed ID: 17709268 [TBL] [Abstract][Full Text] [Related]
8. Fluorophosphonate-Based Degrader Identifies Degradable Serine Hydrolases by Quantitative Proteomics. Field SD; Lee W; Dutra JK; Serneo FSF; Oyer J; Xu H; Johnson DS; Am Ende CW; Seneviratne U Chembiochem; 2020 Oct; 21(20):2916-2920. PubMed ID: 32501609 [TBL] [Abstract][Full Text] [Related]
9. Discovery of potent and specific fructose-1,6-bisphosphatase inhibitors and a series of orally-bioavailable phosphoramidase-sensitive prodrugs for the treatment of type 2 diabetes. Dang Q; Kasibhatla SR; Reddy KR; Jiang T; Reddy MR; Potter SC; Fujitaki JM; van Poelje PD; Huang J; Lipscomb WN; Erion MD J Am Chem Soc; 2007 Dec; 129(50):15491-502. PubMed ID: 18041834 [TBL] [Abstract][Full Text] [Related]
10. Association between PNPLA3 (rs738409), LYPLAL1 (rs12137855), PPP1R3B (rs4240624), GCKR (rs780094), and elevated transaminase levels in overweight/obese Mexican adults. Flores YN; Velázquez-Cruz R; Ramírez P; Bañuelos M; Zhang ZF; Yee HF; Chang SC; Canizales-Quinteros S; Quiterio M; Cabrera-Alvarez G; Patiño N; Salmerón J Mol Biol Rep; 2016 Dec; 43(12):1359-1369. PubMed ID: 27752939 [TBL] [Abstract][Full Text] [Related]
11. A genetic variant in proximity to the gene LYPLAL1 is associated with lower hunger feelings and increased weight loss following Roux-en-Y gastric bypass surgery. Bandstein M; Mwinyi J; Ernst B; Thurnheer M; Schultes B; Schiöth HB Scand J Gastroenterol; 2016 Sep; 51(9):1050-5. PubMed ID: 27181159 [TBL] [Abstract][Full Text] [Related]
12. Late-Stage Conversion of Diphenylphosphonate to Fluorophosphonate Probes for the Investigation of Serine Hydrolases. d'Andrea FB; Townsend CA Cell Chem Biol; 2019 Jun; 26(6):878-884.e8. PubMed ID: 30982751 [TBL] [Abstract][Full Text] [Related]
13. Oxime esters as selective, covalent inhibitors of the serine hydrolase retinoblastoma-binding protein 9 (RBBP9). Bachovchin DA; Wolfe MR; Masuda K; Brown SJ; Spicer TP; Fernandez-Vega V; Chase P; Hodder PS; Rosen H; Cravatt BF Bioorg Med Chem Lett; 2010 Apr; 20(7):2254-8. PubMed ID: 20207142 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of benzothiazole-based analogues as novel, potent, and selective fatty acid amide hydrolase inhibitors. Wang X; Sarris K; Kage K; Zhang D; Brown SP; Kolasa T; Surowy C; El Kouhen OF; Muchmore SW; Brioni JD; Stewart AO J Med Chem; 2009 Jan; 52(1):170-80. PubMed ID: 19072118 [TBL] [Abstract][Full Text] [Related]